HomeJANX • NASDAQ
add
Janux Therapeutics Inc
Previous close
$25.12
Day range
$24.02 - $25.12
Year range
$21.98 - $71.71
Market cap
1.45B USD
Avg Volume
770.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.12M | 98.59% |
Net income | -33.86M | -468.18% |
Net profit margin | — | — |
Earnings per share | -0.55 | -400.00% |
EBITDA | -44.58M | -234.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 996.01M | 54.11% |
Total assets | 1.03B | 49.29% |
Total liabilities | 41.70M | 23.60% |
Total equity | 990.52M | — |
Shares outstanding | 60.09M | — |
Price to book | 1.50 | — |
Return on assets | -10.83% | — |
Return on capital | -11.02% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -33.86M | -468.18% |
Cash from operations | -23.81M | -137.63% |
Cash from investing | 1.56M | 100.82% |
Cash from financing | 954.00K | -65.50% |
Net change in cash | -21.30M | 89.25% |
Free cash flow | -13.70M | -32.61% |
About
Founded
2017
Website
Employees
103
